[First trials on the use of a mixture of 4-butyl-1,2-diphenyl-3,5-pyrazolidinedione and aminopyrine (G-15903) in the treatment of bronchial asthma].
D000632:Aminopyrine; D000700:Analgesics / Q000627:therapeutic use*; D001249:Asthma / Q000628:therapy*; D001713:Biphenyl Compounds; D010653:Phenylbutazone / Q000031:analogs & derivatives
D000632:Aminopyrine; D000700:Analgesics; D001713:Biphenyl Compounds; D010653:Phenylbutazone; C051406:1,2-diphenyl-3,5-pyrazolidinedione; C010574:biphenyl
ANALGESICS/therapeutic use; ASTHMA/therapy
Prīmeiros ensáios sôbre o emprêgo da associação de 3,5-dioxo-1,2-difenil-4-n-butilpirazolidina e dimetilaminofenil-dimetilpirazolona ou G-15.903, no tratamento da asma brônquica.